Skip to search formSkip to main contentSkip to account menu

suxibuzone

Known as: 1,2-diphenyl-4-n-butyl-4-hydroxymethyl-3,5-dioxopyrazolidine hemisuccinate, 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Anti-Inflammatory Agents, Non-SteroidalPhenylbutazone
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Rapid confirmatory analysis of non-steroidal anti-inflammatory drugs in bovine milk by rapid resolution liquid chromatography tandem mass spectrometry.
2008
2008
Evaluation of the palatability of three nonsteroidal antiinflammatory top-dress formulations in horses.
The efficacy of top-dress antiinflammatory drugs ultimately depends on a patient's willingness to consume treated feed. The… 
Highly Cited
2001
Highly Cited
2001
Screening procedure for detection of non-steroidal anti-inflammatory drugs and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas…
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used as analgesic and anti-rheumatic drugs, and they are often misused… 
1999
1999
Disposition and tolerance of suxibuzone in horses.
Suxibuzone (SBZ), a nonsteroidal anti-inflammatory drug, was administered to 6 horses at a dose rate of 7.5 mg/kg bwt by… 
1999
1999
Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses.
A disposition and bioequivalence study with a suxibuzone granulated and a suxibuzone paste oral formulation was performed in… 
1993
1993
The disposition of suxibuzone in the horse.
A high performance liquid chromatographic method is described to determine the anti-inflammatory drug suxibuzone (SXB) and its… 
1992
1992
Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
1983
1983
A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis.
One hundred and fifty patients with rheumatoid arthritis received suxibuzone (426 mg/day, equivalent to 300 mg of phenylbutazone… 
1982
1982
Comparison of the absorption, excretion, and metabolism of suxibuzone and phenylbutazone in humans.
The absorption, excretion, and metabolism of a single oral dose of suxibuzone, a new nonsteroidal anti-inflammatory agent, in… 
1980
1980
Simultaneous high-performance liquid chromatographic determination of suxibuzone and its metabolites in plasma and urine.
A high-performance liquid chromatographic method is described for the simultaneous determination of the anti-inflammatory agent… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)